NCT03586115
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Brain Diseases, +13 more
- Locations
-
- Policlinic Hospital Bari, Italy
Clinical trial condition
Hepatic Encephalopathy
Explore clinical trials studying Hepatic Encephalopathy. Study availability and eligibility vary by location and protocol.
143 public trials
20 recruiting studies
Hepatic Encephalopathy trial results
NCT04557774
- Conditions
- Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Liver Disease, +18 more
- Locations
-
- Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital Chuncheon, Gangwondo, South Korea
NCT00740142
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
- Locations
-
- Siriraj Hospital, Mahidol University Bangkok, Thailand
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +18 more
- Locations
-
- Medanta Hospital Gurgaon, India
- Research facility ORG-000333 Gurgaon, India
- Sir Ganga Ram Hospital New Delhi, India
Completed
A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
NCT00298038
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
- Locations
-
Not specified
NCT01842581
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +12 more
- Locations
-
- Banner Research Phoenix, Arizona, United States
- Southern California Liver Centers Coronado, California, United States
- UCSF/Fresno - CRMC Fresno, California, United States
- UCSD Clinical & Translational Research Institute La Jolla, California, United States
NCT03493204
- Conditions
- Ascites, Brain Diseases, Brain Diseases, Metabolic, +13 more
- Locations
-
- The University of Michigan Ann Arbor, Michigan, United States
Completed
Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy
NCT00686920
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
- Locations
-
- Birmingham, Alabama, United States
- Aurora, California, United States
- Fresno, California, United States
- La Jolla, California, United States
NCT02163837
- Conditions
- Behavior, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- CHU St Pierre Brussels, Belgium
Completed
Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)
NCT02488993
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
- Locations
-
- Queen Elizabeth Hospital Birmingham, United Kingdom